Literature DB >> 17314750

[Central apnea developing during treatment with a mandibular advancement device].

L Gindre1, F Gagnadoux, N Meslier, B Fleury, J M Gustin, J L Racineux.   

Abstract

INTRODUCTION: Mandibular advancement (MA) has emerged over the last decade as an alternative solution to nasal continuous airway pressure (nCPAP) for the treatment of obstructive sleep apnea syndrome (OSAS). OBSERVATION: We report the case of a patient with history of chronic atrial fibrillation and moderate supine-dependent OSAS in whom central sleep apneas developed during treatment by a bi-bloc MA device. Central apneas increased with the level of MA and preferentially occurred in the supine position. We hypothesized that mouth opening under excessive mandibular advancement in supine position may have led to pharyngeal narrowing at the base of the tongue and potentially unstable ventilation. Sleep fragmentation that enhanced during progressive MA may also have compromised ventilatory control stability in our patient. Finally, chronic atrial fibrillation may have predisposed to central sleep apneas.
CONCLUSION: Our case report highlights the importance of follow-up nocturnal recordings during progressive MA.

Entities:  

Mesh:

Year:  2006        PMID: 17314750     DOI: 10.1016/s0761-8425(06)71821-6

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  3 in total

1.  The emergence of central sleep apnea after surgical relief of nasal obstruction in obstructive sleep apnea.

Authors:  Cathy Goldstein; Tomasz J Kuzniar
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

2.  Complex sleep apnea unmasked by the use of a mandibular advancement device.

Authors:  Tomasz J Kuźniar; Ružica Kovačević-Ristanović; Thomas Freedom
Journal:  Sleep Breath       Date:  2010-12-29       Impact factor: 2.816

3.  Mandibular Advancement Device-Emergent Central Sleep Apnea Can Resolve Spontaneously: A Case Report.

Authors:  Arjun Mohan; Jennifer Henderson; M Jeffery Mador
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.